Literature DB >> 10945634

Stabilization of the Ras oncoprotein by the insulin-like growth factor 1 receptor during anchorage-independent growth.

M Gatzka1, M Prisco, R Baserga.   

Abstract

R- cells are 3T3 cells derived from mouse embryos with a targeted disruption of the type 1 insulin-like growth factor receptor (IGF-IR) genes. R- cells are refractory to transformation by a variety of viral and cellular oncogenes, including an activated Ras. R- cells stably transfected with an activated Ha-Ras (R-Ras cells) fail to form colonies in soft agar. An IGF-IR truncated at residue 1245 cannot transform R- cells, even when strongly overexpressed. However, the combination of the truncated IGF-IR and an activated Ras induces transformation of R- cells. We show here that the Ras oncoprotein is rapidly degraded when R-Ras cells are grown under anchorage-independent conditions and that signaling from the truncated IGF-IR stabilizes Ras. In monolayer cultures, Ras levels remain constant regardless of the presence or absence of IGF-IR signaling. These results directly explain why Ras cannot transform mouse embryo fibroblasts devoid of IGF-IR. They also suggest a more generalized, alternative mechanism for transformation by Ras and, implicitly, another possible way for targeting Ras in tumor cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10945634

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene.

Authors:  Jianjun Zhang; Haiyan Guo; He Zhang; Haibo Wang; Guanxiang Qian; Xianqun Fan; Andrew R Hoffman; Ji-Fan Hu; Shengfang Ge
Journal:  Cancer       Date:  2010-08-24       Impact factor: 6.860

2.  Two is better than one: combining IGF1R and MEK blockade as a promising novel treatment strategy against KRAS-mutant lung cancer.

Authors:  Ron Chen; E Alejandro Sweet-Cordero
Journal:  Cancer Discov       Date:  2013-05       Impact factor: 39.397

3.  Upregulation of IGF1R by mutant RAS in leukemia and potentiation of RAS signaling inhibitors by small-molecule inhibition of IGF1R.

Authors:  Ellen Weisberg; Atsushi Nonami; Zhao Chen; Erik Nelson; Yongfei Chen; Feiyang Liu; HaeYeon Cho; Jianming Zhang; Martin Sattler; Constantine Mitsiades; Kwok-Kin Wong; Qingsong Liu; Nathanael S Gray; James D Griffin
Journal:  Clin Cancer Res       Date:  2014-09-03       Impact factor: 12.531

4.  KRAS Oncoprotein Expression Is Regulated by a Self-Governing eIF5A-PEAK1 Feed-Forward Regulatory Loop.

Authors:  Ken Fujimura; Huawei Wang; Felicia Watson; Richard L Klemke
Journal:  Cancer Res       Date:  2018-01-10       Impact factor: 12.701

5.  Methionine adenosyltransferase 2B-GIT1 complex serves as a scaffold to regulate Ras/Raf/MEK1/2 activity in human liver and colon cancer cells.

Authors:  Hui Peng; Tony W H Li; Heping Yang; Mary P Moyer; Jose M Mato; Shelly C Lu
Journal:  Am J Pathol       Date:  2015-04       Impact factor: 4.307

6.  2A-DUB/Mysm1 Regulates Epidermal Development in Part by Suppressing p53-Mediated Programs.

Authors:  Christina Wilms; Ioanna Krikki; Adelheid Hainzl; Sonja Kilo; Marius Alupei; Evgenia Makrantonaki; Maximilian Wagner; Carsten M Kroeger; Titus Josef Brinker; Martina Gatzka
Journal:  Int J Mol Sci       Date:  2018-02-28       Impact factor: 5.923

7.  MYSM1/2A-DUB is an epigenetic regulator in human melanoma and contributes to tumor cell growth.

Authors:  Christina Wilms; Carsten M Kroeger; Adelheid V Hainzl; Ishani Banik; Clara Bruno; Ioanna Krikki; Vida Farsam; Meinhard Wlaschek; Martina V Gatzka
Journal:  Oncotarget       Date:  2017-06-27

Review 8.  Novel Regulators of the IGF System in Cancer.

Authors:  Caterina Mancarella; Andrea Morrione; Katia Scotlandi
Journal:  Biomolecules       Date:  2021-02-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.